摘要
目的评价餐后生物等效性试验中受试者食用高脂餐的情况,总结高脂餐食谱制订的考虑因素。方法对完成首都医科大学附属北京朝阳医院Ⅰ期临床试验研究室(以下简称"本中心")两周期、双交叉、餐后生物等效性试验的33例健康受试者的高脂餐食谱、就餐时间、进食量进行分析,对食用西式高脂餐的21例受试者进行就餐感受的问卷调查,调查内容包括食用高脂餐的感受、餐后饱腹感、餐后有无不适、对于中西式高脂餐的选择和对西式高脂餐中接受度不高的成分。结果本中心选择的中式、西式高脂餐对于受试者的进食量均无影响;57. 14%的受试者倾向于食用西式高脂餐,42. 86%的受试者倾向于食用中式高脂餐;西式高脂餐中接受度不高的成分主要有黄油(33. 33%)、纯牛奶(14. 29%)、沙拉酱(14. 29%)、美式培根(9. 52%)。结论本中心选择的中西式高脂餐基本满足试验需要。综合考虑指导原则要求、受试者就餐感受、避免接受度不高的食物成分等因素,制订更为合理的高脂餐食谱,从而提高临床试验质量。
Objective To evaluate the consumption of high-fat meals in fed bioequivalence studies,and to summarize the consideration factors for making the test meal. Methods Meal composition,eating time and food intake of 33 healthy subjects in the two-period,two-sequence crossover bioequivalence (BE) studies under fed conditions were researched. A questionnaire survey was conducted among 21 subjects who ate Western-style high-fat meal. The survey included the dining experience,postprandial fullness,postprandial discomfort,choice of Chinese-style and Western-style high-fat meals,and not high acceptance ingredients in Western-style high-fat meal. Results Both Chinese-style and Western-style high-fat meals had no effect on the intake of the healthy subjects. The results of the questionnaire showed that 57. 14% of the subjects preferred to eat Western-style high-fat meal,while 42. 86% of subjects preferred to eat Chinese-style high-fat meal. Not high acceptance ingredients in Western-style high-fat meal were butter (33. 33%),milk (14. 29%),salad dressing (14. 29%)and bacon (9. 52%). Conclusion Chinese-style and Western-style high-fat meals we used in the BE studies basically meet the requirements. In order to improve the quality of clinical trials,we should make a more reasonable diet of high-fat meals by considering the requirements of guidelines,the dining experience of the subjects and avoiding the food ingredients with not high acceptance.
作者
赵志霞
宋新
李鹏飞
赵瑞
于伟越
周鑫
刘丽宏
ZHAO Zhi-xia;SONG Xin;LI Peng-fei;ZHAO Rui;YU Wei-yue;ZHOU Xin;LIU Li-hong(Department of Pharmacy ,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China;Department of Nutrition,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2018年第24期2876-2878,共3页
The Chinese Journal of Clinical Pharmacology
基金
重大新药创制基金资助项目(2017ZX09101001)